Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
Clinical trial NCT03782636 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03782636
- Sponsor
- University of Oxford
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2023-02-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.